Gianazza, E.; Brioschi, M.; Iezzi, A.; Paglia, G.; Banfi, C.
Pharmacometabolomics for the Study of Lipid-Lowering Therapies: Opportunities and Challenges. Int. J. Mol. Sci. 2023, 24, 3291.
https://doi.org/10.3390/ijms24043291
AMA Style
Gianazza E, Brioschi M, Iezzi A, Paglia G, Banfi C.
Pharmacometabolomics for the Study of Lipid-Lowering Therapies: Opportunities and Challenges. International Journal of Molecular Sciences. 2023; 24(4):3291.
https://doi.org/10.3390/ijms24043291
Chicago/Turabian Style
Gianazza, Erica, Maura Brioschi, Ada Iezzi, Giuseppe Paglia, and Cristina Banfi.
2023. "Pharmacometabolomics for the Study of Lipid-Lowering Therapies: Opportunities and Challenges" International Journal of Molecular Sciences 24, no. 4: 3291.
https://doi.org/10.3390/ijms24043291
APA Style
Gianazza, E., Brioschi, M., Iezzi, A., Paglia, G., & Banfi, C.
(2023). Pharmacometabolomics for the Study of Lipid-Lowering Therapies: Opportunities and Challenges. International Journal of Molecular Sciences, 24(4), 3291.
https://doi.org/10.3390/ijms24043291